Meiji Yasuda Asset Management Co Ltd. bought a new stake in shares of The Clorox Company (NYSE:CLX - Free Report) during the 2nd quarter, according to its most recent filing with the SEC. The firm bought 116,079 shares of the company's stock, valued at approximately $11,079,000. Meiji Yasuda Asset Management Co Ltd. owned 0.10% of Clorox as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds have also recently bought and sold shares of CLX. Wilkins Investment Counsel Inc. boosted its position in Clorox by 250.6% in the 4th quarter. Wilkins Investment Counsel Inc. now owns 55,064 shares of the company's stock valued at $5,552,000 after buying an additional 39,360 shares during the last quarter. Morningstar Investment Management LLC boosted its stake in shares of Clorox by 131.8% during the 4th quarter. Morningstar Investment Management LLC now owns 62,454 shares of the company's stock valued at $6,297,000 after buying an additional 35,506 shares during the last quarter. Bank of America Corp DE boosted its stake in Clorox by 6.1% during the 1st quarter. Bank of America Corp DE now owns 1,405,774 shares of the company's stock valued at $145,680,000 after acquiring an additional 80,618 shares during the last quarter. National Pension Service lifted its position in shares of Clorox by 68.9% during the fourth quarter. National Pension Service now owns 27,537 shares of the company's stock worth $2,777,000 after purchasing an additional 11,233 shares during the last quarter. Finally, Ilmarinen Mutual Pension Insurance Co acquired a new position in Clorox in the fourth quarter worth about $1,966,000. Hedge funds and other institutional investors own 78.53% of the company's stock.
Clorox Stock Performance
Shares of NYSE CLX opened at $107.00 on Monday. The Clorox Company has a 12-month low of $84.70 and a 12-month high of $128.90. The company has a current ratio of 0.66, a quick ratio of 0.38 and a debt-to-equity ratio of 15.80. The company has a market cap of $12.94 billion, a PE ratio of 22.20, a P/E/G ratio of 3.34 and a beta of 0.54. The stock has a 50 day simple moving average of $98.97 and a 200-day simple moving average of $103.07.
Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings results on Monday, August 3rd. The company reported $1.66 EPS for the quarter, beating analysts' consensus estimates of $1.64 by $0.02. The company had revenue of $1.95 billion for the quarter, compared to analyst estimates of $1.91 billion. Clorox had a return on equity of 522.23% and a net margin of 8.74%.The company's quarterly revenue was down 2.0% compared to the same quarter last year. During the same period last year, the company earned $2.87 earnings per share. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. On average, equities research analysts forecast that The Clorox Company will post 5.8 EPS for the current year.
Clorox Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, August 28th. Stockholders of record on Wednesday, August 12th will be given a dividend of $1.25 per share. This is a boost from Clorox's previous quarterly dividend of $1.24. The ex-dividend date is Wednesday, August 12th. This represents a $5.00 annualized dividend and a dividend yield of 4.7%. Clorox's payout ratio is 103.73%.
Analyst Ratings Changes
Several brokerages have issued reports on CLX. The Goldman Sachs Group restated a "sell" rating and set a $83.00 price objective on shares of Clorox in a research note on Friday, May 1st. UBS Group boosted their price target on Clorox from $100.00 to $105.00 and gave the company a "neutral" rating in a report on Tuesday, August 4th. Barclays restated an "underweight" rating and set a $84.00 price objective on shares of Clorox in a research note on Tuesday, August 4th. Deutsche Bank Aktiengesellschaft set a $98.00 price target on shares of Clorox in a research report on Tuesday, August 4th. Finally, Citigroup boosted their price objective on shares of Clorox from $97.00 to $100.00 and gave the company a "neutral" rating in a research report on Tuesday, August 4th. Twelve research analysts have rated the stock with a Hold rating and five have given a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of "Reduce" and an average price target of $102.40.
Check Out Our Latest Research Report on CLX
Clorox Profile
(
Free Report)
The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company's flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.
Clorox's diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.